Antimicrobial 4-oxoquinolizines

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9403818
SERIAL NO

13823187

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention provides novel 4-oxoquinolizine compounds and their uses for a series of broad-spectrum antibiotics having no cross-resistance to existing or emerging classes of antibiotics. In addition the novel 4-oxoquinolizine compounds are useful against CDC Category A and B pathogens The invention also provides pharmaceutical compositions comprising certain 4-oxoquinolizines in combination with subinhibitory concentrations of polymyxin B against clinical isolates which are resistant to quinolones, carbapenems and other antimicrobial agents.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC300 PROFESSIONAL DRIVE GAITHERSBURG MD 20879

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bartels, Christian Allschwil/BL, CH 15 56
Dale, Glenn Basel, CH 7 28
Heim, Jutta Ramlinsburg, CH 20 58
Milligan, Daniel San Francisco, US 9 30
Roussel, Patrick Mulhouse, FR 43 237
Schneider, Peter Bottmingen/BL, CH 261 4897

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 2, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00